DK1761478T3 - En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder - Google Patents

En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder

Info

Publication number: DK1761478T3
Authority: DK; Denmark
Prior art keywords: atomoxetine; impurity; impurities; isolated; producing
Prior art date: 2004-06-28

Application number

DK05771573T

Other languages

English (en)

Inventor

Eugenio Castelli

Alessandra Vailati

Original Assignee

Teva Pharm Fine Chemicals Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-28

Filing date

2005-06-28

Publication date

2008-12-15

2005-06-28 Application filed by Teva Pharm Fine Chemicals Srl filed Critical Teva Pharm Fine Chemicals Srl

2008-12-15 Application granted granted Critical

2008-12-15 Publication of DK1761478T3 publication Critical patent/DK1761478T3/da

Links

229960002430 atomoxetine Drugs 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 title 2
239000012535 impurity Substances 0.000 title 2
LUCXVPAZUDVVBT-UNTBIKODSA-N atomoxetine hydrochloride Chemical compound Cl.O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C LUCXVPAZUDVVBT-UNTBIKODSA-N 0.000 abstract 2
238000006243 chemical reaction Methods 0.000 abstract 2
IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 abstract 1
229960002828 atomoxetine hydrochloride Drugs 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000010959 commercial synthesis reaction Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Epoxy Compounds (AREA)

DK05771573T 2004-06-28 2005-06-28 En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder DK1761478T3 (da)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US58364304P	2004-06-28	2004-06-28
US58364404P	2004-06-28	2004-06-28
US58364104P	2004-06-28	2004-06-28
US60971604P	2004-09-14	2004-09-14
US62206504P	2004-10-25	2004-10-25
US65233205P	2005-02-11	2005-02-11
US65233005P	2005-02-11	2005-02-11
US65233105P	2005-02-11	2005-02-11
US66666605P	2005-03-30	2005-03-30
US67536905P	2005-04-26	2005-04-26
US68977805P	2005-06-09	2005-06-09
US69073805P	2005-06-14	2005-06-14
PCT/US2005/023423 WO2006004979A2 (en)	2004-06-28	2005-06-28	An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards

Publications (1)

Publication Number	Publication Date
DK1761478T3 true DK1761478T3 (da)	2008-12-15

Family

ID=35783354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05771573T DK1761478T3 (da)	2004-06-28	2005-06-28	En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder

Country Status (11)

Country	Link
US (5)	US7317127B2 (da)
EP (4)	EP1687254A2 (da)
JP (1)	JP2008504302A (da)
KR (2)	KR20070001250A (da)
AT (1)	ATE407111T1 (da)
CA (5)	CA2561866A1 (da)
DK (1)	DK1761478T3 (da)
ES (1)	ES2313387T3 (da)
IL (5)	IL180353A0 (da)
PL (1)	PL1761478T3 (da)
WO (5)	WO2006004976A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7439399B2 (en) *	2004-06-28	2008-10-21	Teva Pharmaceutical Fine Chemicals	Processes for the preparation of atomoxetine hydrochloride
WO2006004976A2 (en)	2004-06-28	2006-01-12	Teva Pharmaceutical Fine Chemicals S.R.L.	Process for the preparation of atomoxetine hydrochloride
CN1976894A (zh)	2004-07-22	2007-06-06	特瓦药物精化学品股份有限公司	阿托莫西汀盐酸盐的多形体
WO2006037055A1 (en) *	2004-09-27	2006-04-06	Dr. Reddy's Laboratories Ltd.	Synthesis of atomoxetine hydrochloride
JP2008501721A (ja) *	2005-04-05	2008-01-24	テバファーマシューティカルファインケミカルズソチエタレスポンサビリタリミテ	安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
US8515185B2 (en) *	2009-11-25	2013-08-20	Google Inc.	On-screen guideline-based selective text recognition
WO2011161690A1 (en) *	2010-06-23	2011-12-29	Symed Labs Limited	Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof
WO2015001565A2 (en) *	2013-07-02	2015-01-08	Zcl Chemicals Limited	"an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof"
CN104628768A (zh) *	2015-03-06	2015-05-20	江苏正大清江制药有限公司	一种伊班膦酸钠的制备方法
CN108929236A (zh) *	2017-05-26	2018-12-04	万特制药(海南)有限公司	盐酸托莫西汀的制备
CN110194719B (zh) *	2019-06-12	2020-05-15	山东大学	一种r-(-)-盐酸阿托莫西汀的制备方法
CN113336654B (zh) *	2020-02-18	2022-12-09	上海医药工业研究院	一种n-甲基-3-(2-甲基苯氧基)苯丙胺的制备方法
CN113358773B (zh) *	2021-05-21	2022-09-13	健民药业集团股份有限公司	一种检测盐酸托莫西汀对映异构体的反相液相色谱方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4194009A (en) *	1974-01-10	1980-03-18	Eli Lilly And Company	Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) *	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
ZA817863B (en) *	1980-11-14	1983-06-29	Lilly Co Eli	(-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant
US4777291A (en) *	1985-02-27	1988-10-11	Eli Lilly And Company	Racemization process
DK630987D0 (da) *	1987-12-01	1987-12-01	Ferrosan As	Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
US4868344A (en) *	1988-03-30	1989-09-19	Aldrich-Boranes, Inc.	Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
DE4123253A1 (de)	1991-07-15	1993-01-21	Schneider Manfred Prof Dr	Verfahren zur enzymatischen racematspaltung halogenierter arylalkanole
HU9202128D0 (en)	1992-06-26	1992-10-28	Richter Gedeon Vegyeszet	Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine
US5658590A (en) *	1995-01-11	1997-08-19	Eli Lilly And Company	Treatment of attention-deficit/hyperactivity disorder
GB9812413D0 (en) *	1998-06-10	1998-08-05	Glaxo Group Ltd	Compound and its use
AU3219800A (en)	1999-03-29	2000-10-16	Eli Lilly And Company	Stereospecific method for preparing tomoxetine and intermediates thereof
JP2002541235A (ja) *	1999-04-09	2002-12-03	イーライ・リリー・アンド・カンパニー	３−アリールオキシ−３−アリールプロピルアミン及びその中間体の製造方法
AU4010000A (en)	1999-04-26	2000-11-10	Eli Lilly And Company	Epimerization reaction for the production of r-fluoxetine
WO2006004976A2 (en)	2004-06-28	2006-01-12	Teva Pharmaceutical Fine Chemicals S.R.L.	Process for the preparation of atomoxetine hydrochloride
CN1976894A (zh)	2004-07-22	2007-06-06	特瓦药物精化学品股份有限公司	阿托莫西汀盐酸盐的多形体

2005
- 2005-06-28 WO PCT/US2005/023419 patent/WO2006004976A2/en not_active Ceased
- 2005-06-28 KR KR1020067022415A patent/KR20070001250A/ko not_active Ceased
- 2005-06-28 US US11/170,379 patent/US7317127B2/en not_active Expired - Fee Related
- 2005-06-28 CA CA002561866A patent/CA2561866A1/en not_active Abandoned
- 2005-06-28 PL PL05771573T patent/PL1761478T3/pl unknown
- 2005-06-28 US US11/169,995 patent/US7507861B2/en not_active Expired - Fee Related
- 2005-06-28 EP EP05771266A patent/EP1687254A2/en not_active Withdrawn
- 2005-06-28 ES ES05771573T patent/ES2313387T3/es not_active Expired - Lifetime
- 2005-06-28 DK DK05771573T patent/DK1761478T3/da active
- 2005-06-28 CA CA002560899A patent/CA2560899A1/en not_active Abandoned
- 2005-06-28 US US11/170,430 patent/US7378553B2/en not_active Expired - Fee Related
- 2005-06-28 WO PCT/US2005/023423 patent/WO2006004979A2/en not_active Ceased
- 2005-06-28 CA CA002561387A patent/CA2561387A1/en not_active Abandoned
- 2005-06-28 CA CA002561386A patent/CA2561386A1/en not_active Abandoned
- 2005-06-28 EP EP05769184A patent/EP1682485A2/en active Pending
- 2005-06-28 CA CA002561015A patent/CA2561015A1/en not_active Abandoned
- 2005-06-28 US US11/170,378 patent/US7439398B2/en not_active Expired - Fee Related
- 2005-06-28 EP EP05771573A patent/EP1761478B1/en not_active Expired - Lifetime
- 2005-06-28 WO PCT/US2005/023273 patent/WO2006004923A2/en not_active Ceased
- 2005-06-28 WO PCT/US2005/023412 patent/WO2006068662A1/en not_active Ceased
- 2005-06-28 JP JP2007518380A patent/JP2008504302A/ja active Pending
- 2005-06-28 WO PCT/US2005/023421 patent/WO2006004977A2/en not_active Ceased
- 2005-06-28 KR KR1020067022414A patent/KR20070057703A/ko not_active Ceased
- 2005-06-28 US US11/170,429 patent/US7355078B2/en not_active Expired - Fee Related
- 2005-06-28 AT AT05771573T patent/ATE407111T1/de not_active IP Right Cessation
- 2005-06-28 EP EP05856869A patent/EP1704138A1/en not_active Withdrawn
2006
- 2006-12-26 IL IL180353A patent/IL180353A0/en unknown
- 2006-12-26 IL IL180354A patent/IL180354A0/en unknown
- 2006-12-26 IL IL180357A patent/IL180357A0/en unknown
- 2006-12-26 IL IL180356A patent/IL180356A0/en unknown
- 2006-12-26 IL IL180355A patent/IL180355A0/en unknown

Also Published As

Publication number	Publication date
CA2561015A1 (en)	2006-06-29
PL1761478T3 (pl)	2009-04-30
CA2561866A1 (en)	2006-01-12
US20060009489A1 (en)	2006-01-12
WO2006004979A3 (en)	2006-04-13
CA2561386A1 (en)	2006-01-12
US7507861B2 (en)	2009-03-24
WO2006068662A1 (en)	2006-06-29
KR20070057703A (ko)	2007-06-07
IL180354A0 (en)	2007-06-03
EP1761478A2 (en)	2007-03-14
US20060009532A1 (en)	2006-01-12
EP1682485A2 (en)	2006-07-26
IL180357A0 (en)	2007-06-03
WO2006004923A2 (en)	2006-01-12
ATE407111T1 (de)	2008-09-15
EP1704138A1 (en)	2006-09-27
US20060009490A1 (en)	2006-01-12
US20060009530A1 (en)	2006-01-12
WO2006004977A2 (en)	2006-01-12
EP1687254A2 (en)	2006-08-09
WO2006004977A3 (en)	2006-04-13
KR20070001250A (ko)	2007-01-03
WO2006004979A2 (en)	2006-01-12
IL180355A0 (en)	2007-06-03
IL180353A0 (en)	2007-06-03
ES2313387T3 (es)	2009-03-01
WO2006004976A2 (en)	2006-01-12
CA2561387A1 (en)	2006-01-12
US7378553B2 (en)	2008-05-27
US7355078B2 (en)	2008-04-08
WO2006004976A3 (en)	2006-02-16
JP2008504302A (ja)	2008-02-14
CA2560899A1 (en)	2006-01-12
IL180356A0 (en)	2007-06-03
WO2006004923A3 (en)	2006-04-20
US20060009531A1 (en)	2006-01-12
US7439398B2 (en)	2008-10-21
EP1761478B1 (en)	2008-09-03
US7317127B2 (en)	2008-01-08

Publication	Publication Date	Title
WO2006027705A3 (en)	2006-07-13	Synthesis of triethylenetetramines
UA93861C2 (uk)	2011-03-25	Спосіб одержання n-фенілпіразол-1-карбоксамідів та сполука аніліну
UA95600C2 (en)	2011-08-25	Synthesis scheme for lacosamide
UA100367C2 (uk)	2012-12-25	Спосіб одержання мемантину і його гідрохлориду
NO20072494L (no)	2007-07-02	Fast farmasoytisk forbindelse som omfatter donepezil-hydroklorid
IL180357A0 (en)	2007-06-03	An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
CY1108804T1 (el)	2014-04-09	Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
TW200740769A (en)	2007-11-01	Novel process
MX2007010141A (es)	2007-09-27	Procesos para la preparacion de intermedios de linezolid.
PT1401802E (pt)	2008-05-30	Processo para a preparação de isocianatos
WO2006020348A3 (en)	2006-06-08	Polymorphs of atomoxetine hydrochloride
TW200612959A (en)	2006-05-01	Method for preparing hydroxamic acids
NO20064884L (no)	2006-10-26	Kjemisk fremgangsmate og ny krystallinsk form
EA200700550A1 (ru)	2007-10-26	Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
TW200740729A (en)	2007-11-01	Methods for preparing glutamic acid derivatives
TNSN06260A1 (en)	2007-12-03	Process for the preparation of tryptase inhibitors
NO20076307L (no)	2007-12-07	Fremgangsmater for a fremstille biarylurinstoffer og analoger derav
TW200738650A (en)	2007-10-16	Process for synthesis of aryloxy diaminopyrimidines
EA200600977A1 (ru)	2006-10-27	Способы получения венлафаксина и формы i венлафаксина гидрохлорида
TW200635914A (en)	2006-10-16	Process for preparing substituted thiophenesulfonyl isocyanates
EA200701163A1 (ru)	2007-12-28	Способ получения анилинов
TW200621734A (en)	2006-07-01	Process for preparing diarylcycloalkyl derivatives
EA200601563A1 (ru)	2006-12-29	Водно-изопропанольный сольват оланзапина
ATE417055T1 (de)	2008-12-15	Steroid modifizierte solatriosen
EA200800044A1 (ru)	2008-06-30	Производные 2,5-бисдиамин[1,4]бензохинона